Clinical Trial Update: L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updates on the comparison of levodopa versus dopamine agonists after subthalamic nucleus deep brain stimulation in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dopamine agonists (dopamine agonists)
• Levodopa (L-dopa) (levodopa)

Snippet

Sponsor: University of Toronto | Conditions: Parkinson's Disease | Phase 2 | Status: UNKNOWN